Lipid/Metabolic
Metabolic syndrome prevalent in elderly Chinese
April 20, 2006 | Lisa Nainggolan

Beijing, China - Almost half of elderly Chinese in Beijing have metabolic syndrome, probably as a result of people there adopting Western diets and lifestyles, a new study shows [1].

And those with metabolic syndrome had a 50% to 70% higher risk of cardiovascular disease (CVD) compared with those who didn't have it, Dr Yao He (Chinese PLA General Hospital, Beijing, China) and colleagues report in the April 18, 2006 issue of the Journal of the American College of Cardiology.

They also showed that a newer definition of metabolic syndrome—proposed last year by the International Diabetes Federation (IDF)—might be more suitable in Asians than the traditional NCEP criteria.


Prevalence of metabolic syndrome higher in women than in men

He et al say this is the first study to examine the relationship between the prevalence of metabolic syndrome and the odds of CVD in a population-based study in China.

They conducted a cross-sectional study in an urban Beijing sample of 2334 participants aged 60 to 95 years (943 men, 1391 women) and looked at the prevalence of metabolic syndrome using two different definitions—the NCEP criteria and the new IDF classification. The latter uses gender- and ethnicity-specific cutoff points for central obesity as measured by waist circumference.

The IDF definition may be more appropriate for Asians than the NCEP criteria, because Asian people tend to have a higher percentage of body fat, particularly abdominal visceral fat, than do white people with the same body-mass index, say He et al.

"Thus, the use of NCEP criteria in Chinese and other Asian populations could underestimate the prevalence of metabolic syndrome and fail to identify many individuals at risk for future CVD."

By the NCEP criteria, the prevalence of metabolic syndrome was 30.5% (17.6% in men, 39.2% in women), but use of the IDF definition significantly increased the prevalence to 46.3% (34.8% in men, 54.1% in women).

The fact that the prevalence of metabolic syndrome was much higher in women than in men is consistent with results from previous studies in Taiwan, Hong Kong, and mainland China, the researchers say.

Regardless of the definition used, subjects with metabolic syndrome had higher odds of coronary heart disease, stroke, and peripheral arterial disease. But the odds were higher with the IDF classification than with the NCEP.

Odds ratios of CV by the NCEP and IDF criteria

Metabolic syndrome by different criteria
CHD (n=784)
Stroke (n=378)
PAD (n=461)
CHD, stroke, or PAD (n=1219)
NCEP (glucose >6.1 mmol/L)
1.43
1.45
1.47
1.50
NCEP (glucose >5.6 mmol/L)*
1.58
1.53
1.37
1.57
IDF
1.69
1.58
1.42
1.73

*A modified NCEP definition using a lower cutoff point of fasting glucose

To download table as a slide, click on slide logo below

"Our study indicates that metabolic syndrome is highly prevalent in the elderly Chinese living in urban Beijing, especially among women. New IDF criteria . . . seem to be more pertinent than those from NCEP for screening and estimating risk in Chinese populations," He et al note.

"Developing effective public-health strategies for the prevention, detection, and treatment of metabolic syndrome should be an urgent priority to reduce the social and medical burden of CVD in China," they conclude.

Source
  1. He Y, Jiang B, Wang J, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006; 47:1588-1594.




You have to be logged in to add a comment to this article
Login
Username 
Password 
  Forgot your password?
 
Remember me on this computer
 
Join theheart.org community
Five reasons to become a member of the most trusted source of cardiology news:
1Be part of the conversation in our blogs and discussion forum
2Share your thoughts on our news or educational programs
3Receive exclusive newsletters related to your field of interest
4Access unique continuous medical education content
5See and read what leaders have to say about cardiology today
It is free and it only takes five minutes to join!
 
button
Previews
Featured CME
Inside: Lipid/Metabolic
Lipid/Metabolic
Sep 8, 2008 10:00 EDT
Navigating the SEAS: Join Drs Fitchett and Chan as they present their views on the latest controversial findings from clinical on treating aortic stenosis with statins alone or in combination with ezetimibe.